Novavax, Inc. (“Novavax”) announced that FDA approved its Biologics License Application (“BLA”) for Nuvaxovid™ for active ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

Panel members had questions about whether a new FDA proposal to require randomized trials for vaccines in healthy adults ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

The Centers for Disease Control and Prevention will no longer recommend that healthy children and pregnant women receive the COVID-19 vaccine, the Trump administration announced Tuesday. “Last ...

Just a week after the FDA updated its stance on new COVID-19 | The CDC's recommended immunization schedule no longer includes ...

The move underscores the profound impact HHS Secretary Robert F. Kennedy is exerting on immunizations in the U.S.

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.